TELA Bio, Inc.
TELA
$0.9596
-$0.0124-1.28%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 18.91% | 5.10% | 3.22% | 11.36% | -5.35% |
| Total Depreciation and Amortization | 25.25% | 6.21% | 2.50% | -33.73% | -31.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -98.53% | -108.94% | -109.99% | -108.47% | -9.35% |
| Change in Net Operating Assets | -145.29% | 9.23% | 76.76% | 33.12% | 62.85% |
| Cash from Operations | -1.81% | -10.61% | -3.93% | -4.24% | -0.27% |
| Capital Expenditure | -61.87% | -105.75% | -54.93% | -22.89% | 29.93% |
| Sale of Property, Plant, and Equipment | 45,233.33% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 636.60% | 636.60% | 600.00% | -- |
| Cash from Investing | 843.07% | 406.34% | 375.87% | 355.12% | 68.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -6.72% | -98.85% | -99.39% | 35.05% | 34.21% |
| Repurchase of Common Stock | -27.68% | 28.17% | 30.82% | 32.67% | 23.14% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -6.94% | -99.63% | -99.82% | 14.22% | 13.26% |
| Foreign Exchange rate Adjustments | -82.93% | -173.30% | -84.21% | 261.61% | 213.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.42% | -1,122.03% | -202.57% | 351.87% | 360.20% |